140 related articles for article (PubMed ID: 23183654)
1. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
Meng Q; Lei T; Zhang M; Zhao J; Zhao XH; Zhang M
J Cancer Res Clin Oncol; 2013 Mar; 139(3):509-19. PubMed ID: 23183654
[TBL] [Abstract][Full Text] [Related]
2. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer.
Yu S; Meng Q; Hu H; Zhang M
Int J Clin Exp Pathol; 2014; 7(9):5538-48. PubMed ID: 25337195
[TBL] [Abstract][Full Text] [Related]
3. The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
Wang S; Lei T; Zhang M
PLoS One; 2016; 11(7):e0157759. PubMed ID: 27391608
[TBL] [Abstract][Full Text] [Related]
4. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
5. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis.
Yang YX; Hu HD; Zhang DZ; Ren H
J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778
[TBL] [Abstract][Full Text] [Related]
6. Expression of Annexin A2 and Its Correlation With Drug Resistance and Recurrence of Bladder Cancer.
Hu H; Zhao J; Zhang M
Technol Cancer Res Treat; 2016 Dec; 15(6):NP61-NP68. PubMed ID: 26637476
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
Zhao M; Yu S; Zhang M
Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
[TBL] [Abstract][Full Text] [Related]
8. STAT3 signaling pathway in drug-resistant bladder cancer cell line.
Lei T; Zhou S; Meng Q; Zhang M
J Biol Regul Homeost Agents; 2019; 33(5):1347-1357. PubMed ID: 31912690
[TBL] [Abstract][Full Text] [Related]
9. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
10. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer.
Hu H; Meng Q; Lei T; Zhang M
Clin Exp Med; 2015 Aug; 15(3):361-9. PubMed ID: 24925635
[TBL] [Abstract][Full Text] [Related]
12. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
13. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells.
Shen SH; Gu LJ; Liu PQ; Ye X; Chang WS; Li BS
Chin Med J (Engl); 2008 Mar; 121(5):463-8. PubMed ID: 18364123
[TBL] [Abstract][Full Text] [Related]
15. Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis.
Wang X; Lu Y; Yang J; Shi Y; Lan M; Liu Z; Zhai H; Fan D
J Cancer Res Clin Oncol; 2008 Sep; 134(9):995-1003. PubMed ID: 18309519
[TBL] [Abstract][Full Text] [Related]
16. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study.
Zhu F; Wang Y; Zeng S; Fu X; Wang L; Cao J
OMICS; 2009 Dec; 13(6):467-76. PubMed ID: 20001861
[TBL] [Abstract][Full Text] [Related]
17. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
18. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.
Barboro P; Rubagotti A; Orecchia P; Spina B; Truini M; Repaci E; Carmignani G; Romagnoli A; Introini C; Boccardo F; Carnemolla B; Balbi C
Cell Oncol; 2008; 30(1):13-26. PubMed ID: 18219107
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer.
Lo YW; Lin ST; Chang SJ; Chan CH; Lyu KW; Chang JF; May EW; Lin DY; Chou HC; Chan HL
J Cell Mol Med; 2015 Apr; 19(4):744-59. PubMed ID: 25639359
[TBL] [Abstract][Full Text] [Related]
20. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU].
Tang HH; Zhou M; Liang G
Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
